Cannabis and Pregnancy UK – Safety Guide

Cannabis and Pregnancy in the UK: A Comprehensive Guide

Important Notice: This guide is for informational purposes. Always consult with your GP, midwife, or healthcare provider for personalised medical advice during pregnancy.

Introduction

Cannabis use during pregnancy remains a subject of significant concern for UK healthcare professionals. With increasing availability and changing social attitudes towards cannabis, it is essential for pregnant women to understand the potential risks and what official UK medical guidelines recommend. This comprehensive guide explores the evidence on cannabis during pregnancy, including concerns about THC and CBD, UK medical guidance, and the implications for breastfeeding.

The Risks of Cannabis During Pregnancy

Cannabis contains over 100 active compounds, with tetrahydrocannabinol (THC) being the primary psychoactive ingredient. Research suggests that THC crosses the placental barrier and can affect fetal development. Several potential risks have been identified:

Fetal Development Concerns

Brain Development: THC may interfere with brain development, particularly in areas responsible for memory, learning, and attention. The fetal brain undergoes critical developmental stages during pregnancy, and cannabinoid exposure could potentially disrupt these processes.
Birth Weight: Some studies indicate associations between maternal cannabis use and reduced birth weight, which can have implications for newborn health and development.
Premature Birth: There is evidence suggesting a potential link between cannabis use in pregnancy and increased risk of preterm delivery.
Neural Development: Animal studies have shown that cannabinoids can affect the developing endocannabinoid system, which plays a crucial role in brain formation and neurological function.

Long-term Developmental Effects

Limited longitudinal studies in humans exist, but some research suggests potential long-term consequences including behavioural problems, attention deficit issues, and learning difficulties in children exposed to cannabis prenatally. The developing brain appears particularly vulnerable to cannabinoid exposure during gestation.

UK Medical Guidelines on Cannabis and Pregnancy

The Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of Midwives (RCM), and the UK’s National Institute for Health and Care Excellence (NICE) all advise against cannabis use during pregnancy.

RCOG Recommendations

The Royal College of Obstetricians and Gynaecologists explicitly recommends that women should be advised not to use cannabis during pregnancy. Their guidance emphasises that whilst evidence on human outcomes remains limited, animal studies demonstrate clear effects on fetal brain development. The RCOG suggests that healthcare providers should:

Screen pregnant women for cannabis use during booking appointments and throughout pregnancy
Provide clear information about potential risks
Offer support and referrals to cessation services where appropriate
Avoid judgement and maintain a supportive, non-punitive approach

NICE Guidance

NICE recommends that pregnant women and those planning pregnancy should be advised of the risks associated with cannabis use. This includes both smoked and non-smoked forms. The guidance acknowledges that whilst direct evidence of harm in humans is limited, the precautionary principle should apply given the critical nature of fetal development.

CBD During Pregnancy: Is It Safe?

Cannabidiol (CBD) is increasingly popular as it does not produce the psychoactive effects associated with THC. However, the safety profile of CBD during pregnancy remains poorly understood.

Current Evidence on CBD

Limited Research: Very few studies have examined CBD use in pregnancy, and there is insufficient evidence to declare CBD safe during gestation.
Placental Interaction: Like THC, CBD crosses the placental barrier and reaches the fetus. Its effects on fetal development are not well characterised.
Product Quality: Many CBD products are not regulated and may contain variable amounts of CBD or contaminating substances, including THC.
Drug Interactions: CBD can interact with medications metabolised by the liver, potentially affecting medications taken during pregnancy.

Medical Advice on CBD

UK healthcare providers generally advise against CBD use during pregnancy due to the lack of safety data. The cautious approach reflects a general principle in obstetrics: when evidence of safety is absent, avoidance is recommended. Women using CBD for specific medical conditions should discuss alternatives with their healthcare provider.

Cannabis and Breastfeeding

Cannabis use should also be avoided during breastfeeding, as cannabinoids pass into breast milk and may affect infant development and nutrition.

Risks During Breastfeeding

Breast Milk Transmission: THC and CBD both accumulate in breast tissue and are secreted into breast milk at concentrations higher than those found in maternal blood.
Infant Exposure: Breastfed infants can be exposed to cannabinoids through milk, potentially affecting their developing nervous systems during a critical period of growth.
Developmental Concerns: Exposure during breastfeeding could interfere with infant neurodevelopment, potentially affecting motor development, cognition, and behaviour.
Milk Supply: Some evidence suggests cannabinoid use might affect milk supply and infant feeding patterns.

Breastfeeding Guidance

The UK’s breastfeeding guidelines recommend complete avoidance of cannabis during the breastfeeding period. Mothers should be informed that brief cessation before feeding does not eliminate the risk, as cannabinoids remain in breast tissue for extended periods. If a mother has used cannabis during breastfeeding, she should discuss this with her healthcare provider, who can assess any potential effects on the infant.

Support and Resources for Pregnant Women

If you are pregnant and use cannabis, it is crucial to speak with your healthcare provider. Support is available through:

Your GP or midwife
NHS specialist drug and alcohol services
Local substance misuse services
Pregnancy support organisations

Healthcare professionals are trained to provide non-judgmental support to help you quit safely during pregnancy.

Conclusion

UK medical guidelines consistently advise against cannabis use during pregnancy and breastfeeding. Whilst research on human outcomes continues to evolve, current evidence suggests potential risks to fetal development, birth outcomes, and long-term child development. This includes CBD products, which remain unregulated and understudied in pregnancy.

The safest approach is complete avoidance during pregnancy and breastfeeding. If you are pregnant or planning pregnancy and use cannabis, discuss this openly with your healthcare provider, who can provide personalised guidance and connect you with appropriate support services. Your health and your baby’s health are the priority.

This guide reflects guidance from the Royal College of Obstetricians and Gynaecologists, the Royal College of Midwives, and NICE. Always consult official NHS resources and your healthcare provider for the most current information.